Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15

Neurology

Volumn 56, Issue 9, 2001, Pages 1219-1221

  Streffer, J R ^a   Bitzer, M ^a   Schabet, M ^a   Dichgans, J ^a   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOSWELLIC ACID; CYTARABINE; HERBACEOUS AGENT; ISONICOTINIC ACID 2,2 BIS[(2 THIOXO 3(2H) BENZOTHIAZOLYL)METHYL]HYDRAZIDE; LOMUSTINE; NIMUSTINE; TENIPOSIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; LEUKOENCEPHALOPATHY; MALE; PHYTOTHERAPY; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0035826816     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.9.1219     Document Type: Article

References (10)

1. Use of corticosteroids in neuro-oncology
2. Chemotherapy of human malignant glioma: Prevention of efficacy by dexamethasone?
3. WAF/CIP1 protein accumulation
4. Dexamethasone pre-treatment interferes with apoptotic death in glioma cells
5. Salai Guggal-Boswellia serrata. From a herbal medicine to a non redox inhibitor of leukotriene biosynthesis
6. Effects of Boswellia serrata gum resin in patients with ulcerative colitis
7. Die rolle von boswellia-säuren in der therapie maligner gliome
8. Boswellic acids and malignant glioma: Induction of apoptosis but no modulation of drug sensitivity
9. Boswellic acids inhibit glioma growth: A new treatment option?
10. Response criteria for phase II studies of supratentorial malignant glioma